The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Oxford/AstraZeneca Covid-19 vaccine in Nigeria.
The
Director-General of NAFDAC, Dr. Mojisola Adeyeye made the announcement during a
live briefing on Thursday.
She said that
the vaccine can be stored at 2 to 8-degree centigrade.
According to
the NAFDAC Boss, there are three additional vaccines undergoing evaluation, but
the evaluation on Astrazeneca shows that the vaccine is effective against the
UK variant of the virus which has been reported in Nigeria.
Dr Adeyeye
disclosed that the South African variant has not been reported in Nigeria,
adding that the agency has over 30 herbal medicine undergoing review for
listing.
The vaccine
was recently approved by the W.H.O for emergency use, in a press briefing,
NAFDAC says it got the dossier of the vaccine a week ago, and the NAFDAC safety
committee went to work immediately to evaluate its safety and efficacy for
Nigerians.
The
Oxford/AstraZeneca vaccine, also known as ChAdOx1 nCoV-19, or AZD1222, is a
viral vector vaccine. Scientists used an adenovirus, originally derived from
chimpanzees, and modified it with the aim of training the immune system to
mount a strong response against SARS-CoV-2 (the virus that causes COVID-19).
No comments:
Post a Comment